Advanced therapy companies have been rapidly populating over the past few years, making it a high-value, fast-growth market. Key drivers for the market include high rates of clinical trials, accelerated pathways for product approvals, new technologies to support cell and gene therapy manufacturing, and the potential for advanced therapies to revolutionize healthcare. [Read more…]
BioInformant to Sponsor “Cell & Gene Therapy World” and “Stem Cells In Vitro” Conferences
BioInformant is proud and honored to be sponsoring the upcoming conferences “Cell and Gene Therapy World” (#CGTWorld) and “Stem Cells In Vitro” (#SCin). Hosted by the renowned conference organizer Phacilitate, the events are being held in combination with each other on January 25-27th, 2016, at the Grand Hyatt Hotel in Washington, DC. In addition to sponsoring the event, BioInformant will be attending the event. [Read more…]
